FindMyRecallSubscribe
Class I: serious health riskOngoing

Alvogen Fentanyl Transdermal System CII Recall

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-co…

Alvogen, Inc · Morristown, NJ

Risk level
Class I
Reported by FDA
Feb 26, 2025
Recall ID
D-0245-2025
Check your lot numberHow we source this data

Summary

Alvogen recalled Fentanyl Transdermal System CII starting Jan 31, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0245-2025 on Feb 26, 2025. Reason: Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch. Status: Ongoing.

Why it was recalled

Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

Product description

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

Lot numbers, UPCs & expiration codes

Lot #: 108319, Exp: 04/30/2027

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0245-2025
Classification
Class I
Status
Ongoing
Recall initiated
Jan 31, 2025
FDA report date
Feb 26, 2025
Quantity
112,128 cartons (5 pouches/carton)
Recall type
Voluntary: Firm initiated
Recalling firm
Alvogen, Inc

Original FDA data

Every field from FDA enforcement report D-0245-2025, exactly as published.

Show all FDA fields
City
Morristown
State
NJ
Status
Ongoing
Country
United States
Event ID
96222
Address
44 Whippany Rd Ste 300
Code information
Lot #: 108319, Exp: 04/30/2027
Postal code
07960-4558
Report date
Feb 26, 2025
Product type
Drugs
Recall number
D-0245-2025
Classification
Class I
Recalling firm
Alvogen, Inc
Product quantity
112,128 cartons (5 pouches/carton)
Reason for recall
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.
Distribution pattern
USA Nationwide
Recall initiation date
Jan 31, 2025
Initial firm notification
Letter
Center classification date
Feb 20, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0245-2025, published Feb 26, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls